NEW YORK (GenomeWeb) – The US Food and Drug Administration has issued an untitled letter to direct-to-consumer genetic testing firm DNA4Life requesting additional information on the company's recently launched Pharmacogenetic Report product.
Registering provides access to this and other free content.
Already have an account?Login Now.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
Nature News writes that researchers are still wrangling over the role of the p-value.
In Nature this week: paternal age associated with de novo mutations in children, and more.